HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Elite 50% OFF Act now – get top investing tools Register Now!
Market News Stocks News ETF News Crypto News

Humacyte, Inc

Contributing Author

Recent Articles by Humacyte, Inc

Nov-20
Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Acellular Tissue Engineered Vessel (ATEV) Clinical Results HUMA GlobeNewswire
Nov-13
Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium) HUMA GlobeNewswire
Nov-12
Humacyte Announces Third Quarter 2025 Financial Results and Provides Business Update HUMA GlobeNewswire
Nov-10
Humacyte Announces Presentation of Positive Two-Year Results from Phase 3 Dialysis Access Trial at the American Society of Nephrology's Kidney Week 2025 HUMA GlobeNewswire
Nov-06
Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025 HUMA GlobeNewswire
Oct-30
Humacyte Announces Publication of New Data Comparing Symvess to Autologous Vein in Extremity Arterial Trauma HUMA GlobeNewswire
Oct-07
Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering HUMA GlobeNewswire
Oct-06
Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess HUMA GlobeNewswire
Sep-29
Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus HUMA GlobeNewswire
Sep-18
Humacyte Announces Publication of Preclinical Data on Use of the CTEV as a Coronary Artery Bypass Graft (CABG) HUMA GlobeNewswire
Sep-15
Humacyte Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess HUMA GlobeNewswire
Aug-11
Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update HUMA GlobeNewswire
Aug-07
Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 HUMA GlobeNewswire
Jul-23
Humacyte Announces First Symvess Sale to Military Treatment Facility HUMA GlobeNewswire
Jul-08
Humacyte announces Symvess ECAT Approval from U.S. Defense Logistics Agency HUMA GlobeNewswire
Jun-09
Results from Humacyte's V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting HUMA GlobeNewswire
Jun-02
Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3 HUMA GlobeNewswire
May-19
Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq HUMA GlobeNewswire
May-13
Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update HUMA GlobeNewswire
May-09
Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025 HUMA GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.